|
KMID : 0613320130190010009
|
|
Journal of the Korean Bone and Joint Tumor Soceity
2013 Volume.19 No. 1 p.9 ~ p.13
|
|
|
Oncologic Outcome of Chondrosarcomas
|
|
Kim Chol-Jin
Chung Jun-Young
Chung Yang-Guk
Rhee Seung-Koo
Kang Yong-Koo
Park Won-Jong
Shim Jung-In
|
|
|
Abstract
|
|
|
Purpose: We evaluated oncologic outcomes of chondrosarcomas and analyzed the disease-free survival rate of chondrosarcomas according to the various factors.
Materials and Methods: We performed a retrospective study for the disease-free survival rate of 48 chondrosarcomas, 44 of which underwent surgical treatment and followed up more than 18 months since 1993, and in the remaining 4 cases, the patients died before 18 months after surgery. The vsariables were location, tumor volume, histologic grade, stage, age at presentation and treatment performed. The mean follow up period was 43.8 months (1-196 months).
Results: The overall disease-free survival rate was 77.1% at mean 43.8 month follow up. The 5 year- and 10 year disease-free survival rates were 64% and 58% respectively. The histologic grade, stage, age at presentation revealed statistical significance on disease-free survival. All 9 patients treated with extended curettage for grade 1 central chondrosarcomas revealed disease-free survival with excellent functional outcome.
Conclusion: The disease-free survival rate of chondrosarcomas mainly depended on histologic grade, stage and age at presentation. Local recurrence and distant metastasis also revealed statistically significant differences of disease-free survival rate. Comparing to wide resection, extended curettage for low-grade central chondrosarcomas in extremities were efficient methods with similar survival rate and less functional losses and complications.
|
|
|
KEYWORD
|
|
|
chondrosarcoma, oncologic outcome, disease-free survival, prognostic factor
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|